SEC Form 4 · accession 0001127602-18-009042

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 26, 2018

Accepted (ET)

Feb 28, 2018 · 3:30 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2018	S	200	$107.68	D	316,512	D
Common Stock	Feb 26, 2018	S	370	$107.685	D	316,142	D
Common Stock	Feb 26, 2018	S	430	$107.69	D	315,712	D
Common Stock	Feb 26, 2018	S	400	$107.70	D	315,312	D
Common Stock	Feb 26, 2018	S	100	$107.73	D	315,212	D
Common Stock	Feb 26, 2018	S	300	$107.74	D	314,912	D
Common Stock	Feb 26, 2018	S	300	$107.75	D	314,612	D
Common Stock	Feb 26, 2018	S	70	$107.77	D	314,542	D
Common Stock	Feb 26, 2018	S	100	$107.78	D	314,442	D
Common Stock	Feb 26, 2018	S	200	$107.80	D	314,242	D
Common Stock	Feb 26, 2018	S	400	$107.815	D	313,842	D
Common Stock	Feb 26, 2018	S	200	$107.83	D	313,642	D
Common Stock	Feb 26, 2018	S	300	$107.88	D	313,342	D
Common Stock	Feb 26, 2018	S	99	$107.895	D	313,243	D
Common Stock	Feb 26, 2018	S	100	$107.92	D	313,143	D
Common Stock	Feb 26, 2018	S	100	$107.97	D	313,043	D
Common Stock	Feb 26, 2018	S	300	$108.00	D	312,743	D
Common Stock	Feb 26, 2018	S	100	$108.02	D	312,643	D
Common Stock	Feb 26, 2018	S	400	$108.04	D	312,243	D
Common Stock	Feb 26, 2018	S	100	$108.055	D	312,143	D
Common Stock	Feb 26, 2018	S	100	$108.06	D	312,043	D
Common Stock	Feb 26, 2018	S	100	$108.07	D	311,943	D
Common Stock	Feb 26, 2018	S	200	$108.10	D	311,743	D
Common Stock	Feb 26, 2018	S	300	$108.12	D	311,443	D

No Table II lines on this filing.